Nvidia Acknowledges Conceding China AI Chip Market to Huawei as Competition Intensifies Spotify Shares Surge 13 on AI Partnership with Universal Music and 2030 Revenue Guidance Amazon Expands AI Shopping Platform to Retail Partners Signs Kate Spade Qualcomms Stock Surge Signals Rising Investor Confidence in AIDriven Device Revolution CFTC Takes Legal Action Against Rhode Island in Growing Battle Over Prediction Market Regulation Puerto Ricos Top 2026 Travel Destinations Old San Juan and Vieques Highlighted as Tourism Drivers Sprinklr CXM Q1 2026 Earnings EPS Surges Past Estimates by 34 Despite Lack of Revenue Disclosure XRN Q1 2026 Earnings Disappointing Quarter as EPS Misses Estimates Significantly American Financial Group Q1 2026 Earnings EPS Misses Estimates Amid Premium Growth Headwinds DoorDash Q1 2026 Earnings EPS Surpasses Expectations with 1296 Beat RMCO Q4 2025 Earnings Significant EPS Miss as Company Reports Loss MillerKnoll Q1 2026 Earnings EPS Misses Estimates Amid Softening Demand Rigel Pharmaceuticals RIGL Gains Nearly 2 as Stock Tests Key Resistance Near 3124 Petrobras PBR Slips 269 as Oil Sector Headwinds Pressure Shares Getty Images GETY Gains Ground Nears Resistance at 110 Enliven Therapeutics ELVN Pulls Back 263 as Resistance Holds Support Levels in Focus BioLife Solutions BLFS Dips 138 Support Test Looms Chinas AI Media System Ignores Japanese Politicians Condolences After Coal Mine Disaster Akari Therapeutics plc ADS AKTX Q1 2026 Earnings WiderThanExpected EPS Loss Overshadowed by Stock Surge Indaptus Therapeutics INDP Surges 15 Biotech Stock Breaks Above Key Resistance AVGO Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower XOMAP Q1 2026 Earnings Preferred Stock Reports EPS Miss Amid Royalty Revenue Uncertainty Neuropace NPCE Q1 2026 Earnings EPS Beat Surprises Market Stock Gains PLG Q4 2023 Earnings EPS Beat Masks Continued PreRevenue Stage as Stock Declines Arch Capital Group Ltd Depositary Shares Series G ACGLN Q1 2026 Earnings Preferred EPS Slightly Misses Estimates Stock Holds Steady ASMB Q1 2026 Earnings Narrower Loss Surprises Market Shares Jump 694 Day One Biopharmaceuticals Q4 2025 Earnings EPS Miss Amid Continued RD Investment